95 related articles for article (PubMed ID: 23190153)
1. Downregulation but lack of promoter hypermethylation or somatic mutations of the potential tumor suppressor CXXC5 in MDS and AML with deletion 5q.
Treppendahl MB; Möllgård L; Hellström-Lindberg E; Cloos P; Grønbaek K
Eur J Haematol; 2013 Mar; 90(3):259-60. PubMed ID: 23190153
[No Abstract] [Full Text] [Related]
2. Epigenetic changes in therapy-related MDS/AML.
Voso MT; D'Alò F; Greco M; Fabiani E; Criscuolo M; Migliara G; Pagano L; Fianchi L; Guidi F; Hohaus S; Leone G
Chem Biol Interact; 2010 Mar; 184(1-2):46-9. PubMed ID: 19874806
[TBL] [Abstract][Full Text] [Related]
3. CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes.
Benetatos L; Hatzimichael E; Dasoula A; Dranitsaris G; Tsiara S; Syrrou M; Georgiou I; Bourantas KL
Leuk Res; 2010 Feb; 34(2):148-53. PubMed ID: 19595458
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
Wong JJ; Lau KA; Pinello N; Rasko JE
Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia.
Kühnl A; Valk PJ; Sanders MA; Ivey A; Hills RK; Mills KI; Gale RE; Kaiser MF; Dillon R; Joannides M; Gilkes A; Haferlach T; Schnittger S; Duprez E; Linch DC; Delwel R; Löwenberg B; Baldus CD; Solomon E; Burnett AK; Grimwade D
Blood; 2015 May; 125(19):2985-94. PubMed ID: 25805812
[TBL] [Abstract][Full Text] [Related]
9. Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.
Benetatos L; Dasoula A; Hatzimichael E; Syed N; Voukelatou M; Dranitsaris G; Bourantas KL; Crook T
Ann Hematol; 2011 Sep; 90(9):1037-45. PubMed ID: 21340720
[TBL] [Abstract][Full Text] [Related]
10. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
11. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
Ye Y; McDevitt MA; Guo M; Zhang W; Galm O; Gore SD; Karp JE; Maciejewski JP; Kowalski J; Tsai HL; Gondek LP; Tsai HC; Wang X; Hooker C; Smith BD; Carraway HE; Herman JG
Cancer Res; 2009 Nov; 69(21):8482-90. PubMed ID: 19826047
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the p15(INK4B) gene in acute leukemia and myelodysplastic syndromes.
Chen H; Wu S
Chin Med J (Engl); 2002 Jul; 115(7):987-90. PubMed ID: 12150726
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic modifications in AML and MDS.
Mahmud M; Stebbing J
Leuk Res; 2010 Feb; 34(2):139-40. PubMed ID: 19665226
[No Abstract] [Full Text] [Related]
14. Submicroscopic deletions in 5q- associated malignancies.
Crescenzi B; La Starza R; Romoli S; Beacci D; Matteucci C; Barba G; Aventin A; Marynen P; Ciolli S; Nozzoli C; Martelli MF; Mecucci C
Haematologica; 2004 Mar; 89(3):281-5. PubMed ID: 15020265
[TBL] [Abstract][Full Text] [Related]
15. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
[TBL] [Abstract][Full Text] [Related]
16. ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia.
Otto N; Manukjan G; Göhring G; Hofmann W; Scherer R; Luna JC; Lehmann U; Ganser A; Welte K; Schlegelberger B; Steinemann D
Leukemia; 2011 Jul; 25(7):1202-7. PubMed ID: 21475251
[No Abstract] [Full Text] [Related]
17. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?
Galván AB; Mallo M; Arenillas L; Salido M; Espinet B; Pedro C; Florensa L; Serrano S; Solé F
Leuk Res; 2010 Sep; 34(9):1242-5. PubMed ID: 20362335
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
Li XL; Arai Y; Harada H; Shima Y; Yoshida H; Rokudai S; Aikawa Y; Kimura A; Kitabayashi I
Oncogene; 2007 Nov; 26(51):7231-9. PubMed ID: 17533375
[TBL] [Abstract][Full Text] [Related]
19. [Methylation status of LINE-1 sequences in patients with MDS or secondary AML].
Römermann D; Hasemeier B; Metzig K; Schlegelberger B; Länger F; Kreipe H; Lehmann U
Verh Dtsch Ges Pathol; 2007; 91():338-42. PubMed ID: 18314632
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
